Word

CR

Status

Registered

Status Code

700

Status Date

Tuesday, April 25, 2023

Serial Number

79339085

Registration Number

7033274

Registration Date

Tuesday, April 25, 2023

Mark Type

3000

Filing Date

Wednesday, February 23, 2022

Published for Opposition

Tuesday, February 7, 2023

Trademark Owner History

Corregene Biotechnology Co., Ltd - Original Registrant

Classifications

5 Chemical reagents for medical or veterinary purposes; disinfectants; radioactive substances for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; nutritive substances for microorganisms cultures; diagnostic preparations for medical purposes; Biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; surgical implants comprised of living tissues; veterinary preparations for the prevention and treatment of intestinal bacteria, colibacillosis, salmonellosis, pasteurella, brucellosis, foot-and-mouth disease, tuberculosis, plague, infectious diseases, influenza, immune related diseases and nutrient deficiency related diseases; preparations for destroying noxious animals

42 Product quality testing services; technological research in the field of medicines and biological preparations; research and development of pharmaceuticals for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; genome structure and function analysis; genetic testing for scientific research purposes; Medical and scientific research, namely, conducting clinical trials for others; The testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical products

The mark consists of an abstract design consisting of circular and curved line shapes depicting the letters "CR".

Trademark Events

Aug 4, 2023

Final Disposition Notice Sent To Ib

Aug 4, 2023

Final Disposition Processed

Jul 25, 2023

Final Disposition Notice Created, To Be Sent To Ib

Apr 25, 2023

Notice Of Registration Confirmation Emailed

Apr 25, 2023

Registered-Principal Register

Feb 7, 2023

Notification Processed By Ib

Feb 7, 2023

Official Gazette Publication Confirmation E-Mailed

Feb 7, 2023

Published For Opposition

Jan 18, 2023

Notification Of Possible Opposition Sent To Ib

Jan 18, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 18, 2023

Notification Of Notice Of Publication E-Mailed

Jan 5, 2023

Approved For Pub - Principal Register

Dec 16, 2022

Teas/Email Correspondence Entered

Dec 15, 2022

Correspondence Received In Law Office

Dec 15, 2022

Teas Response To Office Action Received

Nov 15, 2022

Refusal Processed By Ib

Oct 22, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Oct 21, 2022

Refusal Processed By Mpu

Aug 31, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Aug 30, 2022

Non-Final Action Written

Aug 25, 2022

Assigned To Examiner

May 3, 2022

Application Filing Receipt Mailed

Apr 29, 2022

New Application Office Supplied Data Entered

Apr 28, 2022

Sn Assigned For Sect 66a Appl From Ib